Ulrich Knigge

Medicine & Life Sciences

1. Neuroendocrine Tumors 100%
2. 64Cu-DOTATATE 48%
3. Neuroendocrine Carcinoma 39%
4. Neoplasms 31%
5. Somatostatin Receptors 18%
6. Chromogranin A 16%
7. Histamine 16%
8. Edotreotide 16%
9. Carcinoid Tumor 16%
10. Gastro-enteropancreatic neuroendocrine tumor 15%
11. Survival 14%
12. Radioisotopes 14%
13. Peptide Receptors 12%
14. Fluorodeoxyglucose F18 11%
15. Neoplasm Metastasis 11%
16. Somatostatin 10%
17. Therapeutics 10%
18. Guidelines 10%
19. Progression-Free Survival 10%
20. Arginine Vasopressin 10%
21. somatostatin receptor 2 9%
22. Vasopressins 8%
23. Positron-Emission Tomography 8%
24. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 8%
25. Ga(III)-DOTATOC 7%
26. Prolactin 7%
27. alovudine 6%
28. Etoposide 6%
29. Octreotide 6%
30. Multiple Endocrine Neoplasia Type 1 6%
31. 2-(2-aminoethyl)thiazole 6%
32. beta-Endorphin 6%
33. Thymus Neoplasms 6%
34. Cohort Studies 6%
35. Adrenocorticotropic Hormone 6%
36. Insulinoma 5%
37. von Hippel-Lindau Disease 5%
38. Lung 5%
39. Radionuclide Imaging 5%
40. Gene Expression 5%
41. Gastrointestinal Tract 5%
42. Liver 5%
43. Biomarkers 5%